PPT-Intact HIV proviruses persist in the brain despite viral suppression with antiretroviral

OAA03 Finding the needle in the haystack Progress in understanding the HIV reservoir Michael Roche PhD Department of Infectious Diseases The University of Melbourne at the Peter Doherty Institute for Infections and Immunity Australia. Council of State and Territorial Epidemiologists Annual Conference. June 4, 2012. Omaha, Nebraska. Tom Jaenicke, MPH, MBA, MES. Washington State Department of Health. Tom.Jaenicke@doh.wa.gov. Outline for today. May 21, . 2013. . For Audio: Dial-in#: 866.394.2346 Participant Code: 397 154 6368#. Welcome & . Overview, . 5 . mins. Maximizing Virologic Suppression, . 35 . mins. Panel Discussion . Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). In the Classroom. January/February 2013 issue . of . Radiologic . Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Diseases. “Human Immunodeficiency Virus. Infection-Antiretroviral . Therapy. ”-1. . Dr. Sabin Thomas, M. Pharm. Ph. D.. Assistant . Professor. in . Pharmacy. Practice. School. of . Pharmacy. , CPN. Virus (HIV) . Infection. Zoya. . Minasyan. RN-MSN-. Edu. Significance of Problem. Globally. 33 million living with HIV. 2.7 million new infections each year. 2 million HIV-related deaths each year. Jeffrey B. Joy, Richard H. Liang, Rosemary M. McCloskey, Thuy Nguyen, Chanson J. Brumme, Guillaume Colley, Robert S. Hogg, Julio S.G. Montaner, P. Richard Harrigan, and Art F.Y. Poon. Conflict of Interest. New Orleans, LA . December 15, 2015 . Laura Cheever, MD, . ScM. Associate Administrator. Department of Health and Human Services. Health Resources and Services Administration. ACTIVITY CODE . TD342. Antiretroviral Medications: . What . you need to know. Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP. Associate Professor, Department of Pharmacy Practice. Therapy. Evidence, Implication and Preliminary Findings from . an Implementation . Research . in Viet Nam. Masaya . Kato, WHO Viet . Nam. National Scientific Conference on HIV/AIDS. 24-25 November 2015, Hanoi, Viet Nam. 3130293029283029283029282927262631302931 Compositionintact skin2827 Special precautions for use PRODUCT EXTERNAL USE ONLYUse of topical products especially if prolonged may cause hypersensitivity n th John T. Brooks, MD . Senior Medical Advisor, CDC Division of HIV/AIDS Prevention. Dr. Brooks has no relevant financial affiliations to disclose. Sexual Transmission Reduced with Lower Blood Viral Load. . Trikudanathan. , MD, MRCP, . MMSc. Division of Endocrinology, Metabolism and Nutrition. University of Washington Medical Center. Presentation prepared by: . S. . Trikudanathan. Presenter: S. . Trikudanathan. Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection.